Shares of United Cannabis Corp (OTC BB: CNAB), engaged in advancing the use of cannabinoids in medicine through research, product development and education., recorded over 25.0% gain during each of the past two consecutive trading sessions with significant number of shares exchanging hands. CNAB was among the top performers in the U.S healthcare sector after gaining 25.0% and closed at $1.60 Wednesday, while recording significant trading volumes of 343,035 shares. Recently, the company has signed a consulting and licensing agreement with FoxBarry Farms, LLC, whereby FoxBarry will be the exclusive licensee and distributor of United Cannabis branded medical marijuana products in the State of California. During the past 5-trading sessions, CNAB gained 128.5% with daily average trading volumes of 189,138 shares, while the stock accumulated 166.6% gain during the past one month with daily average trading volumes of 53,266 shares. The stock is up 146.1% year-to-date.
Company Description:
United Cannabis Corp (OTC BB: CNAB) (formerly known as MySkin Inc.) is engaged in advancing the use of cannabinoids in medicine through research, product development and education. The company’s A.C.T. Now Program and patent-pending Prana Bio Nutrient Medicinals provide a comprehensive solution designed to enable physicians and patients to design, implement and monitor effective therapy protocols.
1-Year Stock Chart:
Source: Bloomberg
